The IMS Corporate Liaison Board (CLB) members demonstrate dedication to the vision and mission of the IMS, and a commitment to furthering the field of mid-life women’s health. CLB members play an active role in enhancing the IMS’s global reach and gain early insight into the trends and breakthroughs that will shape tomorrow’s business landscape.
The current CLB members are:
- Abbott Product Operations A.G.
- Astellas Pharma Europe Ltd
- Bayer Consumer Care A.G.
- Besins Healthcare Pharma Services
- Gedeon Richter UK Ltd
- Lawley Pharmaceuticals Pty Ltd
- Novo Nordisk Health Care A.G.
- Pfizer Inc
- Vichy Laboratoires
For more information about joining the CLB, please contact the IMS CEO, Rebecca Cheshire, on firstname.lastname@example.org